How were (NSPH)'s earnings last quarter?

(NSPH) (NASDAQ:NSPH) announced its earnings results on Monday, May, 16th. The medical research company reported ($0.55) earnings per share for the quarter, topping analysts' consensus estimates of ($0.59) by $0.04. The medical research company earned $6.60 million during the quarter, compared to analyst estimates of $6.50 million. (NSPH)'s revenue for the quarter was up 43.5% on a year-over-year basis. During the same period in the previous year, the company posted ($1.29) earnings per share.

What other stocks do shareholders of (NSPH) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (NSPH) investors own include Cerus (CERS) , Aeterna Zentaris (AEZS) , Actinium Pharmaceuticals (ATNM) , BIOLASE (BIOL) , Molecular Templates (MTEM) , Northwest Biotherapeutics (NWBO) , Sarepta Therapeutics (SRPT) , XOMA (XOMA) , Cypress Semiconductor (CY) and Equity Bancshares (EQBK) .

NASDAQ:NSPH

(NSPH) (NSPH) Stock Price, News & Analysis

→ Forget NVIDIA, buy this $2 AI stock now… (From Behind the Markets) (Ad)

Free NSPH Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $1.69
▼
$1.69
50-Day Range: N/A
52-Week Range: $0.48
▼
$3.64

Volume: N/A
Average Volume: 886,293 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (NSPH) alerts:

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

About (NSPH) Stock (NASDAQ:NSPH)

Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

NSPH Stock News Headlines

April 13, 2023 | msn.com

LIVE FEED: Police, Correctional Services give update on Thabo Bester, Dr Nandipha Magudumana’s arrests

March 8, 2023 | msn.com

Michelle Yeoh deletes post some saw as a slam on fellow Oscar nominee Cate Blanchett

April 19, 2024 | Behind the Markets (Ad)

Forget NVIDIA, buy this $2 AI stock now…

This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.

December 29, 2022 | msn.com

Titans' Teair Tart takes a spill trying to celebrate fumble vs. Cowboys

December 17, 2022 | msn.com

Polls open in Tunisian parliamentary election boycotted by opposition

December 17, 2022 | msn.com

Top 10 customer hacks making workers’ lives miserable

November 21, 2022 | msn.com

San Mateo: After 40 years, Windy City restaurant, Da Bears fan hangout closes today

August 20, 2022 | thestreet.com

8 Stocks Under $10 Surging Higher

April 19, 2024 | Behind the Markets (Ad)

Forget NVIDIA, buy this $2 AI stock now…

This company is at the center of a trillion-dollar industry, fighting for a piece of a massive $20 billion pentagon contract.

August 18, 2022 | msn.com

Nitish Kumar snubs BJP’s ‘jungle raj returns’ allegation, says will respond at an appropriate time

August 6, 2022 | msn.com

More afternoon downpours and storms Sunday

December 14, 2021 | usnews.com

Logic's Hit '1-800-273-8255' May Have Saved American Lives

See More Headlines

Receive NSPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NSPH) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/16/2016
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:NSPH
CUSIP: N/A
CIK: 1105184
Web: www.nanosphere.us
Phone: +1-847-4009000
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

NSPH Stock Analysis - Frequently Asked Questions

How were (NSPH)'s earnings last quarter?: (NSPH) (NASDAQ:NSPH) announced its earnings results on Monday, May, 16th. The medical research company reported ($0.55) earnings per share for the quarter, topping analysts' consensus estimates of ($0.59) by $0.04. The medical research company earned $6.60 million during the quarter, compared to analyst estimates of $6.50 million. (NSPH)'s revenue for the quarter was up 43.5% on a year-over-year basis. During the same period in the previous year, the company posted ($1.29) earnings per share.
What other stocks do shareholders of (NSPH) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (NSPH) investors own include Cerus (CERS), Aeterna Zentaris (AEZS), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL), Molecular Templates (MTEM), Northwest Biotherapeutics (NWBO), Sarepta Therapeutics (SRPT), XOMA (XOMA), Cypress Semiconductor (CY) and Equity Bancshares (EQBK).

This page (NASDAQ:NSPH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(NSPH) (NSPH) Stock Price, News & Analysis

About (NSPH) Stock (NASDAQ:NSPH)

NSPH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

NSPH Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info